Pardes Hanna, Israel

Ori Kalid

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovative Contributions of Ori Kalid

Introduction

Ori Kalid is a prominent inventor based in Pardes Hanna, Israel, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Kalid has made remarkable advancements in the development of compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Kalid has developed substituted benzofuranyl and benzoxazolyl compounds, which are particularly relevant in the treatment of cancer, including mantle cell lymphoma. This invention focuses on a compound represented by Structural Formula A, along with its pharmaceutically acceptable salts. The synthesis and application of these compounds are aimed at addressing various diseases and disorders. Another notable patent involves nuclear transport modulators, which relate to compounds that can influence CRM1 activity. This invention includes pharmaceutical compositions and methods for treating disorders associated with this activity.

Career Highlights

Kalid has worked with notable companies such as Karyopharm Therapeutics Inc. and Ramot at Tel-Aviv University Ltd. His work in these organizations has allowed him to contribute to cutting-edge research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Kalid has collaborated with esteemed colleagues, including Erkan Baloglu and Sharon Shacham. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Ori Kalid's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations highlight his commitment to developing new treatments for serious health conditions. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…